The Generative Brain

Eating and swallowing: more detail

Plain explanation

Dysphagia in prion disease is managed through speech and language therapy assessment, texture modification, mouth care and a single shared care plan, with decisions on clinically assisted nutrition and hydration taken as best-interests decisions and reviewed as the illness changes. Two exceptions are recognised: early dysphagia in A117V, and gastrointestinal disturbance in PrP truncation variants.

The family-facing version is eating and swallowing. This page is for people who are asked to explain or support these decisions: counsellors, clinicians new to prion disease, and carers who want the reasoning rather than the summary.

The shape of the problem

Swallowing deteriorates as the disease progresses, and oral feeding can become actively harmful through aspiration. That is the clinical fact underneath every decision here. The 2026 multidisciplinary recommendations for palliative and supportive care in CJD set out the approach, and their framing is worth noting: the risks of continuing oral feeding have to be weighed against the benefits, and against the psychological harm of stopping.

Two causes of reduced intake can look identical at the bedside and have different answers. One is the mechanical and neurological failure of swallowing. The other is refusal, which the recommendations attribute either to the cognitive changes of the illness or to being hand-fed by unfamiliar people. The second is sometimes solved by changing who feeds the person and where, and it is worth excluding before a swallowing conclusion is drawn.

What risk reduction consists of

Where oral feeding continues, the recommendations name four components together: a speech and language therapy assessment, dietary modifications, good oral and dental care, and a clear shared care plan. The last of these does more work than it appears to. In a disease that progresses over weeks, families commonly receive different advice from a hospital team, a community nurse, a care agency and a relative who has read something, and a single documented plan is what prevents mealtimes becoming a negotiation.

Saliva management is a separate problem from swallowing food, and the recommendations handle it separately: good oral care, attention to head positioning, gentle anterior oral suction, and anticholinergic medication, specifically glycopyrronium or hyoscine hydrobromide, used with caution. Caution here is not a formality, since anticholinergic load worsens confusion and dry mouth, and dry mouth makes oral care harder.

How assisted nutrition decisions are framed

Clinically assisted nutrition and hydration is handled as a best-interests decision. The recommendations describe reviewing capacity, taking input from family and the multidisciplinary team, and reassessing regularly rather than deciding once.

Two statements in the guidance carry most of the weight in these conversations. The first is that tube feeding prolongs the akinetic-mute period, the late stage in which a person is awake but unable to move or speak. The second is that national guidance advises clinically assisted nutrition and hydration should not routinely be used in severe dementia unless the contributing problem is potentially reversible. Taken together these make the default position in advanced prion disease a conservative one, and they also explain why a family can feel that the medical answer is settled before their own question has been heard.

The honest way to present this is that the default is not an administrative rule and not a judgement about the worth of the person’s remaining life. It is a judgement about whether the intervention achieves something the person would have wanted, in a condition where it extends a stage most people say they would not want extended. Families who disagree are entitled to say so, and the guidance provides for unresolved conflict by noting that legal advice may be needed.

The two recognised exceptions

The general position does not fit every patient, and the recommendations say so.

In inherited prion disease caused by the A117V variant, dysphagia appears early, while the person may be much less impaired in other respects. The guidance states that assisted nutrition is more clearly justifiable in that situation. The reasoning is that the intervention is not prolonging a terminal akinetic stage but supporting someone whose swallowing has failed ahead of the rest of the illness. Background on that variant is on A117V, and Appleby and colleagues describe the Gerstmann-Straussler-Scheinker phenotype it usually produces.

In PRNP truncation variants with gastrointestinal disturbance, the problem is not swallowing at all. The recommendations suggest loperamide first, and that total parenteral nutrition may then be considered. Appleby and colleagues report that nonsense variants are typically associated with PrP amyloid angiopathy, and that Y163X has been described with systemic PrP amyloidosis, diarrhoea and autonomic neuropathy. A person with chronic diarrhoea and autonomic failure is a different clinical problem from a person with end-stage dysphagia, and treating them with the same default would be an error.

Both exceptions depend on knowing the variant, which is one of several reasons genetic results are important to care planning as well as to relatives.

Why practice differs between countries

The recommendations note real international variation. Tube feeding is common in Japan. In Germany its use has declined, and feeding through the stomach wall is now reserved for exceptional cases, while access can depend on insurance processes. In the United States care is more dispersed, without a national care fund or a routine specialist nursing service of the kind that exists in the UK.

This becomes visible when a family compares notes with a family elsewhere, or reads guidance written for another system. The clinical reasoning travels; the default practice, the funding and the person who coordinates it do not. Country-specific routes are on countries.

Assessment tools and their limits

Several proxy-completed tools are used at this stage of the illness, including IPOS-Dem and observational pain scales such as PAINAD, DisDAT and the Abbey pain scale. The recommendations state that these are not validated in prion disease. They remain useful as a structured way of recording change over time, and they should not be presented to a family as objective measurement.

The related point on pain is worth carrying into any discussion about mealtime distress. The guidance states that pain in a non-verbal individual may manifest as agitation or restlessness, and calls the caregiver’s collateral history invaluable. Distress at feeding is not automatically about swallowing.

Eating and swallowing, palliative and hospice care, end of life decisions and communication and behaviour changes.

Sources for this page